J. Homsi

发表

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma

Hua Yu, R. Jove, J. Homsi, 2009, Melanoma research.

Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors.

J. Homsi, A. Daud, 2007, Cancer control : journal of the Moffitt Cancer Center.

Immunotherapy of melanoma: an update.

P. Hwu, J. Homsi, J. Grimm, 2011, Surgical oncology clinics of North America.

Psychostimulants in supportive care

D. Walsh, J. Homsi, K. Nelson, 2000, Supportive Care in Cancer.

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration

Benjamin P. C. Chen, R. Collins, Guoqiang Chen, 2018, Nature.

Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function

M. Davies, P. Hwu, J. Homsi, 2011, Journal of clinical pharmacology.

Bioelectrical impedance, cancer nutritional assessment, and ascites

D. Walsh, J. Homsi, N. Sarhill, 2000, Supportive Care in Cancer.

The impact of a palliative medicine consultation service in medical oncology

Mellar P. Davis, D. Walsh, J. Homsi, 2002, Supportive Care in Cancer.

Predictive Biomarkers and Personalized Medicine Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy

Jeffrey E. Lee, M. Ross, A. Lucci, 2011 .

Vascular endothelial growth factor (VEGF) inhibitorsin cancer therapy: An update

J. Homsi, P. Munster, A. Daud, 2006 .

The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

Mellar P. Davis, J. Homsi, 2001, Supportive Care in Cancer.

Symptom evaluation in palliative medicine: patient report vs systematic assessment

Mellar P. Davis, D. Walsh, J. Homsi, 2006, Supportive Care in Cancer.

A phase II study of methylphenidate for depression in advanced cancer

D. Walsh, J. Homsi, L. Rybicki, 2001, The American journal of hospice & palliative care.

Symptom Epidemiology and Clusters

J. Homsi, 2009 .

Hydrocodone for cough in advanced cancer

Mellar P. Davis, D. Walsh, J. Homsi, 2000, The American journal of hospice & palliative care.

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma

Dae Hyun Kim, S. Patel, P. Hwu, 2017, Cancer Immunology, Immunotherapy.

High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition

Melissa A. Wilson, K. Buetow, J. Homsi, 2022, Cancers.

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Sicklick, M. Bui, R. Riedel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Melanoma of the Anal Canal: A Case Series

J. Homsi, C. Garrett, 2007, Diseases of the colon and rectum.

Important drugs for cough in advanced cancer

D. Walsh, J. Homsi, K. Nelson, 2001, Supportive Care in Cancer.

Chemical Castration of Melanoma Patients Does Not Increase the Frequency of Tumor-specific CD4 and CD8 T Cells After Peptide Vaccination

S. Patel, P. Hwu, G. Lizée, 2013, Journal of immunotherapy.

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.

J. Sicklick, S. Dry, M. McCarter, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy

P. Hwu, J. Homsi, Kevin B. Kim, 2012, Supportive Care in Cancer.

Palliative medicine in a United States cancer center: A prospective study

D. Walsh, J. Homsi, J. Cowan, 2002, The American journal of hospice & palliative care.

PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma

A. Hauschild, D. Schadendorf, C. Chung, 2018, The New England journal of medicine.

Infectious complications of advanced cancer

D. Walsh, J. Homsi, R. Lagman, 2014, Supportive Care in Cancer.

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients

P. Hwu, J. Homsi, Kevin B. Kim, 2009, Melanoma research.

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

D. Gerber, Quanzhen Li, E. Wakeland, 2022, Cancers.

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.

A. Hauschild, D. Schadendorf, J. Taube, 2022, The New England journal of medicine.

Common symptoms in advanced cancer.

D. Walsh, J. Homsi, S. Donnelly, 2000, Seminars in oncology.

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Jeffrey E. Lee, V. Johnson, M. Ross, 2012, Clinical Cancer Research.

The Src signaling pathway: a potential target in melanoma and other malignancies

J. Homsi, C. Cubitt, A. Daud, 2007, Expert opinion on therapeutic targets.

The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis

J. Homsi, Akshjot Puri, 2017, Melanoma research.

High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review

J. Bishop, D. Sher, J. Homsi, 2021, Annals of Surgical Oncology.

A Comparative Study of 2 Sustained-Release Morphine Preparations for Pain in Advanced Cancer

D. Walsh, J. Homsi, L. Rybicki, 2010, The American journal of hospice & palliative care.

Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis

J. Homsi, Richard C. Wang, C. Lewis, 2020, Molecular Cancer Research.

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

J. McQuade, J. Homsi, W. Hwu, 2018, BMC Cancer.

Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma

J. Homsi, Brenen P. Swofford, 2017, Case reports in oncological medicine.

Cemiplimab (REGN2810): A fully human anti-PD-1 monoclonal antibody for patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC)—Initial safety and efficacy from expansion cohorts (ECs) of phase I study.

Melissa L. Johnson, T. Owonikoko, I. Lowy, 2017 .

Phase I/II Study of a Cisplatin-Taxol-Dacarbazine Regimen in Metastatic Melanoma

P. Hwu, J. Homsi, Kevin B. Kim, 2009, American journal of clinical oncology.

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

A. Hauschild, A. Testori, M. Del Vecchio, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Cutaneous melanoma: prognostic factors.

J. Homsi, J. Messina, A. Daud, 2005, Cancer control : journal of the Moffitt Cancer Center.

Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study

Mellar P. Davis, D. Walsh, J. Homsi, 2001, The American journal of hospice & palliative care.

Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?

P. Hwu, C. Warneke, J. Homsi, 2011, Melanoma research.

Predictive Biomarkers and Personalized Medicine Speci fi c Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-In fi ltrating Lymphocytes in Metastatic Melanoma Patients

Jeffrey E. Lee, V. Johnson, M. Ross, 2012 .

Phase 2 open-label study of weekly docosahexaenoic acid–paclitaxel in patients with metastatic uveal melanoma

P. Hwu, J. Homsi, Kevin B. Kim, 2010, Melanoma research.

Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy

Jeffrey E. Lee, M. Ross, A. Lucci, 2011, Clinical Cancer Research.

Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma

P. Hwu, Caimiao Wei, J. Homsi, 2011, American journal of clinical oncology.

Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck

P. Hwu, J. Homsi, Kevin B. Kim, 2011, Melanoma research.

Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies

J. Homsi, P. Munster, D. Sullivan, 2007, Clinical Cancer Research.

A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma

P. Hwu, J. Homsi, Kevin B. Kim, 2009, Cancer investigation.

Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.

J. Homsi, C. Garrett, 2006, Cancer control : journal of the Moffitt Cancer Center.

BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma

A. Lazar, S. Patel, P. Hwu, 2012, Journal of cutaneous pathology.

Symptoms and survival in patients with advanced disease.

J. Homsi, D. Luong, 2007, Journal of palliative medicine.

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

J. McQuade, J. Homsi, R. Bassett, 2018, BMC Cancer.

Symptom severity and distress in advanced cancer

Mellar P. Davis, D. Walsh, J. Homsi, 2010, Palliative medicine.

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors

Laurentiu M. Pop, R. Hannan, Yuanyuan Zhang, 2023, Translational oncology.

Symptom assessment in cancer patients

J. Homsi, M. Naughton, 2002, Current oncology reports.

NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.

J. Sicklick, M. Bui, R. Riedel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma

J. Homsi, Jennifer G. Gill, Sophia Wix, 2023, JAAD Case Reports.

Common complications of advanced cancer.

D. Walsh, J. Homsi, S. Legrand, 2000, Seminars in oncology.